Table 3.
Comparing Clinical Outcomes Between Men and Womena
| Sex | No. Patients | No. Events | 5-Y Event rate (95% CI) | Adjusted Hazard Ratio (95% CI)b | P Valuec |
|---|---|---|---|---|---|
| DFS | |||||
| Men | 18,237 | 7634 | 0.62 (0.61–0.63) | 1.12 (1.08–1.16) | <.0001 |
| Women | 15,092 | 5735 | 0.65 (0.64–0.66) | Reference | |
| OS | |||||
| Men | 18,245 | 6550 | 0.70 (0.70–0.71) | 1.13 (1.09–1.17) | <.0001 |
| Women | 15,101 | 4893 | 0.73 (0.72–0.73) | Reference | |
| TTR | |||||
| Men | 18,225 | 6271 | 0.66 (0.65–0.67) | 1.05 (1.01–1.09) | .0073 |
| Women | 15,085 | 5005 | 0.67 (0.67–0.68) | Reference | |
Abbreviations: DFS = disease-free survival; OS = overall survival; TTR = time to recurrence.
a
All analyses were stratified by study.
b
Adjusting for age, stage, and treatment.
c
Likelihood ratio test of Cox proportional hazard model.